No profile data available.
Carlsmed, Inc. (CARL) is a healthcare company in the bone and joint treatment equipment industry, based in Carlsbad, United States, with about 89 full-time employees.
It reported revenue of $50.51 million for fiscal year 2025, up 85.9% from fiscal year 2024, and net income of -$30.22 million. Its market capitalization was $383.20 million as of December 4, 2025.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of December 4, 2025.
, a commercial-stage company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures.
Carlsmed reported $50.51 million in revenue for fiscal year 2025, up 85.9% from $27.17 million in fiscal year 2024.
$383.20 million as of December 4, 2025.
Listed companies of a similar size in the same industry (bone and joint treatment equipment) include Bioventus Inc. (BVS), Si-bone, Inc. (SIBN), OrthoPediatrics Corp. (KIDS), Orthofix Medical Inc. (OFIX).